scholarly journals Pars plana vitrectomy with intravitreal triamcinolone: effect on uveitic cystoid macular oedema and treatment limitations

2006 ◽  
Vol 91 (3) ◽  
pp. 345-348 ◽  
Author(s):  
M. Gutfleisch ◽  
G. Spital ◽  
A. Mingels ◽  
D. Pauleikhoff ◽  
A. Lommatzsch ◽  
...  
Keyword(s):  
Macular Oedema ◽  
Pars Plana Vitrectomy ◽  
Cystoid Macular Oedema ◽  
Intravitreal Triamcinolone ◽  
Pars Plana

scholarly journals Inflammation and Macular Oedema after Pars Plana Vitrectomy

2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
Vito Romano ◽  
Martina Angi ◽  
Fabrizio Scotti ◽  
Renata del Grosso ◽  
Davide Romano ◽  
...  
Keyword(s):  
Macular Oedema ◽  
Pars Plana Vitrectomy ◽  
Extracellular Fluid ◽  
Cystoid Macular Oedema ◽  
Therapeutic Approaches ◽  
Fluid Accumulation ◽  
Primary Defect ◽  
Blood Retinal Barrier ◽  
Vasogenic Oedema ◽  
Pars Plana

Cystoid macular oedema (CMO) is a major cause of reduced vision following intraocular surgery. Although the aetiology of CMO is not completely clarified, intraocular inflammation is known to play a major role in its development. The macula may develop cytotoxic oedema when the primary lesion and fluid accumulation occur in the parenchymatous cells (intracellular oedema) or vasogenic oedema when the primary defect occurs in the blood-retinal barrier and leads to extracellular fluid accumulation (extracellular oedema). We report on the mechanisms of CMO formation after pars plana vitrectomy and associated surgical procedures and discuss possible therapeutic approaches.

scholarly journals Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy

2015 ◽  
Vol 2015 ◽  
pp. 1-3 ◽  
Author(s):  
Eric K. Newcott ◽  
Abdallah A. Ellabban ◽  
Shokufeh Tavassoli ◽  
Ahmed Sallam
Keyword(s):  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Macular Oedema ◽  
Intravitreal Bevacizumab ◽  
Imatinib Therapy ◽  
Cystoid Macular Oedema ◽  
Imatinib Treatment ◽  
Intravitreal Triamcinolone ◽  
Fellow Eye

Purpose.To evaluate the efficacy of intravitreal bevacizumab and triamcinolone in the treatment of cystoid macular oedema in a case with chronic myeloid leukaemia on imatinib treatment.Methods.We treated a 78-year-old man with bilateral cystoid macular oedema with intravitreal triamcinolone and subsequent bevacizumab in one eye and intravitreal bevacizumab, alone, in the fellow eye.Results.Serial intravitreal bevacizumab with and without triamcinolone treated cystoid macular oedema in both eyes and improved the vision.Conclusion.Intravitreal bevacizumab and triamcinolone could be viable options to treat cystoid macular oedema due to chronic myeloid leukaemia and imatinib therapy.

Full-thickness macular hole in a patient with diabetic cystoid macular oedema treated by intravitreal triamcinolone injections

2007 ◽  
Vol 85 (7) ◽  
pp. 795-798 ◽  
Author(s):  
Amélie Lecleire-Collet ◽  
Olivier Offret ◽  
David Gaucher ◽  
François Audren ◽  
Belkacem Haouchine ◽  
...  
Keyword(s):  
Macular Hole ◽  
Macular Oedema ◽  
Cystoid Macular Oedema ◽  
Full Thickness ◽  
Intravitreal Triamcinolone ◽  
Full Thickness Macular Hole
Sign in / Sign up

Export Citation Format

Share Document